GlassScriptPhysician profile
Lucy Yuan
NPI 1588296859
$1,938.45
in general payments reported to CMS, 2019-2025
8 companies · $1,585 in 2025
The $1,585 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.99 · 2022: $50.38 · 2023: $165 · 2024: $37.94 · 2025: $1,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,023 · Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,023.22 |
| Food and Beverage | $764.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,227.53 | 2025 | |
| Sight Sciences, INC. | $292.05 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $250.10 | 2024-2025 | Clareon, Rocklatan |
| Allergan, INC. | $99.99 | 2021 | |
| Glaukos Corporation | $25.03 | 2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Carl Zeiss Meditec Cataract Technology INC. | $17.91 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $13.14 | 2024 | Quatera 700 |
| Rxsight INC | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Yuan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.